Type
Closure
Country
France
Region
Bassin Parisien; Champagne-Ardenne; Marne
Location of affected unit(s)
Reims
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.10 - Manufacture of basic pharmaceutical products

120 jobs
Number of planned job losses
Job loss
Announcement Date
22 September 2022
Employment effect (start)
1 October 2022
Foreseen end date
31 December 2024

Description

The management of AstraZeneca has confirmed the forthcoming closure of its site at Reims (Marne). All the 120 employees will be affected by the decision. The pharmaceutical group is looking for a suitable buyer and promises to support the 120 employees during this transition period. The group has presented to staff representatives a project to sell its operational packaging and distribution activities at the Reims site by the end of 2024. The plant, which packages and distributes medicines, will be no longer part of AstraZeneca's plans and projects. The reason behind the decision is the loss of a patent on an anti-diabetic mainly packaged at this site.  The decision was denounced by the unions.


Sources

Citation

Eurofound (2022), AstraZeneca, Closure in France, factsheet number 107427, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/107427.